- Anax Metals Ltd: Danny George has been appointed as Chief Operating Officer
- ANZ Group Holdings Ltd: ANZ Bank New Zealand Chief Executive Officer and Group Executive Antonia Watson will be retiring at the end of FY26. Antonia will be replaced by ANZ New Zealand Chief Risk Officer Ben Kelleher.
- Arovella Therapeutics Ltd: Professor Cameron Turtle has been appointed to the Clinical Advisory Board, and Dr Sam Fiorenza has been appointed as Lead Principal Investigator for its first-in-human clinical trial for ALA-101.
- Ausgold Ltd: John Sofield has been appointed as Project Director.
- Bapcor Ltd: Andrew Fraser has been appointed as an Independent Non-Executive Director, effective 1 July 2026.
- Bellavista Resources Ltd: Darren Cooke will join the Board as a Non-Executive Director. Michael Wilson has resigned as a Director but has been appointed as a Technical Consultant.
- Block, Inc.: Engineering Lead Arnaud Weber has departed from the Company.
- Compumedics Ltd: Mike Stone has been appointed as Chief Commercial Officer for its United States operations.
- Core Lithium Ltd: Greg English will retire as Chairman of Core Lithium and will be appointed as Chairman of Axiant Resources Ltd, the proposed spin-out, effective 30 June 2026
- Energy One Ltd: Guy Steel has announced his resignation as Chief Financial Officer, effective 31 August 2026.
- Future Generation Global: Sharon Cook OAM will join the Board as an Independent Director.
- Helia Group Ltd: Mark Senkevics has been appointed as Chief Executive Officer and Managing Director, effective 1 December 2026. Craig Ward will be appointed Chief Financial Officer from 1 July 2026.
- Intelligent Monitoring Group Ltd: Chris Taylor has been appointed as a Non-Executive Director, effective 1 July 2026.
- Klevo Rewards Ltd: Andrew Shi has been appointed as an Executive Director and Chief Investment Officer
- L1 Group Ltd: James Allaway has been appointed as Chief Financial Officer, succeeding Andrew Stannard. James will commence in September 2026. At that point, Andrew will move to an advisory role to support the transition, before leaving the Company in early 2027.
- Lendlease Group: Nick O’Neil has been appointed as Group Chief Executive Officer and Managing Director, effective 10 September 2026
- Pilbara Gold Ltd: Martin Reed has been appointed as a Non-Executive Director. Jeff Bowen has been appointed as Study Manager. Non-Executive Director Robert Klug will step down from the Board to become Chief Legal and Financial Officer in a full-time capacity.
- Prescient Therapeutics Ltd: Dr Rosalind Wilson has been appointed as Chief Medical Officer, effective 13 July 2026.
- QBE Insurance Group Ltd: Christopher Harris has been appointed as an Independent Non-Executive Director, effective 6 July 2026
- Serko Ltd: David Holyoke has been appointed as Chief Product Officer.
